Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 1,694

The DOI matches its Crossref record; 83 of the 83 references it cites were found in a registry or an index.

The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics

Open access
Jang, Dan-in, Lee, A-Hyeon, Shin, Hye-Yoon, Song, Hyo-Ryeong, Park, Jong-Hwi, Kang, Tae-Bong, Lee, Sang-Ryong, Yang, Seung-Hoon·2021·International Journal of Molecular Sciences

Abstract

Tumor necrosis factor alpha (TNF-α) was initially recognized as a factor that causes the necrosis of tumors, but it has been recently identified to have additional important functions as a pathological component of autoimmune diseases. TNF-α binds to two different receptors, which initiate signal transduction pathways. These pathways lead to various cellular responses, including cell survival, differentiation, and proliferation. However, the inappropriate or excessive activation of TNF-α signaling is associated with chronic inflammation and can eventually lead to the development of pathological complications such as autoimmune diseases. Understanding of the TNF-α signaling mechanism has been expanded and applied for the treatment of immune diseases, which has resulted in the development of effective therapeutic tools, including TNF-α inhibitors. Currently, clinically approved TNF-α inhibitors have shown noticeable potency in a variety of autoimmune diseases, and novel TNF-α signaling inhibitors are being clinically evaluated. In this review, we briefly introduce the impact of TNF-α signaling on autoimmune diseases and its inhibitors, which are used as therapeutic agents against autoimmune diseases.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3390/ijms22052719

Cites

83 of 83 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

1 retracted

Show all 83 references

Research works printed but not linked: 14

  1. Morita, 2001, Association of tumor necrosis factor receptor type II polymorphism 196R with Systemic lupus erythematosus in the Japanese: Molecular and functional analysis, Arthritis Rheum., 44, 2819, 10.1002/1529-0131(200112)44:12<2819::AID-ART469>3.0.CO;2-2 · doi:10.1002/1529-0131(200112)44:12<2819::aid-art469>3.0.co;2-2
  2. Hasan, 2007, Angiotensin-Converting enzyme gene polymorphism in patients with psoriatic arthritis, Rheumatol. Int., 27, 1119, 10.1007/s00296-007-0349-y · doi:10.1007/s00296-007-0349-y
  3. Ringheanu, 2004, Effects of infliximab on apoptosis and reverse signaling of monocytes from healthy individuals and patients with Crohn’s disease, Inflamm. Bowel Dis., 10, 801, 10.1097/00054725-200411000-00015 · doi:10.1097/00054725-200411000-00015
  4. Rosenbaum, 2019, New observations and emerging ideas in diagnosis and management of non-infectious uveitis: A review, Semin. Arthritis Rheum., 49, 438, 10.1016/j.semarthrit.2019.06.004 · doi:10.1016/j.semarthrit.2019.06.004
  5. Fearon, 2018, The pathogenic role of dendritic cells in non-infectious anterior uveitis, Exp. Eye Res., 173, 121, 10.1016/j.exer.2018.05.008 · doi:10.1016/j.exer.2018.05.008
  6. Reddy, S.P., Shah, V.V., Lin, E.J., and Wu, J.J. (2016). Therapy for Severe Psoriasis, Elsevier.
  7. Tan, 2007, Mechanisms of action of etanercept in psoriasis, J. Investig. Dermatol. Symp. Proc., 12, 38, 10.1038/sj.jidsymp.5650037 · doi:10.1038/sj.jidsymp.5650037
  8. Brambilla, A., and Simonini, G. (2016). Handbook of Systemic Autoimmune Diseases, Elsevier.
  9. LaMattina, 2017, Adalimumab for the treatment of uveitis, Expert Rev. Clin. Immunol., 13, 181, 10.1080/1744666X.2017.1288097 · doi:10.1080/1744666x.2017.1288097
  10. Rosa, 2016, An evidence-based review of certolizumab pegol in the treatment of active psoriatic arthritis: Place in therapy, Open Access Rheumatol., 8, 37
  11. Desai, 2012, Mixed Treatment Comparison of the Treatment Discontinuations of Biologic Disease-Modifying Antirheumatic Drugs in Adults with Rheumatoid Arthritis, Ann. Pharmacother., 46, 1491, 10.1345/aph.1R203 · DOI
  12. Shealy, 2007, Characterization of golimumab (CNTO 148), a novel fully human monoclonal antibody specific for human TNFα, Ann. Rheum. Dis., 66, 151
  13. Mazumdar, 2009, Golimumab, mAbs, 1, 422, 10.4161/mabs.1.5.9286 · doi:10.4161/mabs.1.5.9286
  14. Dahmus, 2020, Risk of Lymphoma Associated with Anti-TNF Therapy in Patients with Inflammatory Bowel Disease: Implications for Therapy, Clin. Exp. Gastroenter., 13, 339, 10.2147/CEG.S237646 · doi:10.2147/ceg.s237646

Cited by

See all 1,694

Metadata

Authors
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H.
Venue
International Journal of Molecular Sciences
Publisher
MDPI AG
Published
2021-03-08
Volume
22
Issue
5
Pages
2719
ISSN
1422-0067 (ISSN-L)
OpenAlex
W3134454558
Cited by
1,694
References
83
FWCI
141.32
Type
journal article
Language
en
Open access
gold
Funders
  • Dongguk University Research Fund of 2019 (S-2019-G0001-00009)
  • Cooperative Research Program for Agriculture Science &amp; Technology Development of Rural Development Administration in Republic of Korea (Project No. PJ014297)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. https://app.cochat.ai/papers/10.3390/ijms22052719
The paper
Jang, D.-I., Lee, A.-H., Shin, H.-Y., Song, H.-R., Park, J.-H., Kang, T.-B., Lee, S.-R., & Yang, S.-H. (2021). The Role of Tumor Necrosis Factor Alpha (TNF-α) in Autoimmune Disease and Current TNF-α Inhibitors in Therapeutics. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22052719

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.